Premier Fund Managers LTD Neuronetics, Inc. Transaction History

Premier Fund Managers LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$2.81 - $6.71 $270,277 - $645,394	-96,184 Reduced 52.35%	87,561 $255,000
Q4 2022 Feb 09, 2023	BUY	$2.74 - $6.87 $497,022 - $1.25 Million	181,395 Added 7718.94%	183,745 $1.2 Million
Q4 2022 Feb 08, 2023	SELL	$2.74 - $6.87 $825,822 - $2.07 Million	-301,395 Reduced 99.23%	2,350 $245,000
Q2 2022 Aug 08, 2022	SELL	$2.09 - $3.71 $223,648 - $397,003	-107,009 Reduced 26.05%	303,745 $2.64 Million
Q1 2021 May 10, 2021	BUY	$10.6 - $21.27 $3.5 Million - $7.02 Million	329,854 Added 407.73%	410,754 $5 Million
Q3 2020 Nov 13, 2020	BUY	$1.82 - $5.87 $13,650 - $44,025	7,500 Added 10.22%	80,900 $408,000
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.61 $103,494 - $191,574	73,400 New	73,400 $143,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $82.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Premier Fund Managers LTD with notifications on news.